本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NRX Pharmaceuticals Inc.

3.40
-0.0900-2.58%
盤前3.400.0040+0.12%07:50 EDT
成交量:125.71萬
成交額:414.45萬
市值:1.47億
市盈率:-4.38
高:3.47
開:3.46
低:3.16
收:3.49
52周最高:5.06
52周最低:1.62
股本:4,329.58萬
流通股本:3,742.14萬
量比:1.92
換手率:3.36%
股息:- -
股息率:- -
每股收益(TTM):-0.7754
每股收益(LYR):-1.3374
淨資產收益率:-682.61%
總資產收益率:-63.99%
市淨率:-865.92
市盈率(LYR):-2.54

資料載入中...

2021/07/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/07

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/06

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/25

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/05/28

重要事件披露

8-K - Current report
2021/05/28

重要事件披露

8-K - Current report
2021/05/26

重要事件披露

8-K - Current report
2021/05/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/24

重要事件披露

8-K - Current report
2021/05/24

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/05/24

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/05/21

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/21

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/14

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/05/14

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/11

重要事件披露

8-K - Current report